Search results
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 4 hours agoNobel Laureate Professor Sir Martin Evans opens Molecular Devices' Cardiff facility to manufacture patient-derived organoids for research and drug discovery PR Newswire SAN ...
Targeting leukemia's survival route: A novel approach to overcoming leukemia recurrence
Medical Xpress· 2 days agoResearchers from Karolinska Institutet have, in collaboration with the University of Eastern Finland and Lund University, published a study in Genome Biology demonstrating ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 days agoVisiongain has published a new report: Genome Editing Technologies Market Report 2024-2034: Forecasts by Technology (CRISPR, TALEN, ZFN, Meganucleases, Others), by Application (Genetic Engineering ...
Research Cross-Journal Editorial Team
Nature· 6 days agoResearch Cross-Journal Editorial Team
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
Motley Fool via Yahoo Finance· 6 days agoAs a result, immunosuppressants must be given to any patient who takes the therapy. That's a big...
Genflow Biosciences PLC Announces Receipt of Grant Funding
StreetInsider· 6 days agoTHE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. UPON THE PUBLICATION OF ...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 6 days agoSÖDERTÄLJE, Sweden and SAN FRANCISCO and KYOTO, Japan, May 30, 2024 (GLOBE NEWSWIRE) -- Anocca AB (Anocca), a leading T-cell receptor-engineered T-cell ...
The importance of a disturbed lipid metabolism in Charcot-Marie-Tooth disease
Medical Xpress· 2 days agoCMT disease is a group of inherited disorders that affect the peripheral nerves, leading to muscle weakness and sensory loss in the extremities. Among the various subtypes of CMT, CMT1A is the ...
FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity - Nature...
Nature· 7 days agoThe immunosuppressive tumour microenvironment in Nasopharyngeal carcinoma (NPC) is a cause of low efficacy of immunotherapies in these tumours. In this study, the authors delineate a FLI1-mediated ...
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
The Motley Fool via AOL· 6 days agoAs a result, immunosuppressants must be given to any patient who takes the therapy. That's a big problem since it increases the patient's risk of infection by bacteria...company ...